The 2 references without contexts in paper E. Varyushina A., E. Moskalenko A., T. Lebedeva P., A. Bubnov N., A. Simbirtsev S., Е. Варюшина А., В. Москаленко В., Т. Лебедева П., А. Бубнов Н., А. Симбирцев С. (2014) “ИСПОЛЬЗОВАНИЕ ИНТЕРЛЕЙКИНА-1β ДЛЯ МЕСТНОГО ЛЕЧЕНИЯ ГНОЙНО-НЕКРОТИЧЕСКИХ ПОРАЖЕНИЙ НИЖНИХ КОНЕЧНОСТЕЙ // INTERLEUKIN-1β APPLICATION FOR LOCAL TREATMENT OF PURULENT AND NECROTIC LESIONS OF LOWER EXTREMITIES” / spz:neicon:mimmun:y:2008:i:5:p:439-448

5
Jude E.B., Blakytny R., Bulmer J., Boulton A.J., Ferguson M.W. Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers // Diabet. Med. – 2002. – Vol. 19. – P. 440-447.
(check this in PDF content)
10
Nolan C.M., Beaty H.N., Bagdade J.D. Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes // Diabetes. – 1978. – Vol. 27. – Р. 889-894.
(check this in PDF content)